Balstilimab trials for Colorectal cancer
All Balstilimab trials · All Colorectal cancer trials
8
Recruiting trials
Phase breakdown
Phase 1 2Phase 2 6
Recruiting trials studying Balstilimab for Colorectal cancer
- A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
- Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
- FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
- KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
- Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
- Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
- Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)
- RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer
Common questions
How many trials study Balstilimab for Colorectal cancer?
8 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.